HEMOGLOBIN A1C, BLOOD PRESSURE, and LDL-CHOLESTEROL CONTROL among HISPANIC/LATINO ADULTS with DIABETES

RESULTS from the HISPANIC COMMUNITY HEALTH STUDY/STUDY of LATINOS (HCHS/SOL)

Sarah Stark Casagrande, Larissa Aviles-Santa, Leonor Corsino, Martha L. Daviglus, Linda C. Gallo, Rebeca A. Espinoza Giacinto, Maria Llabre, Samantha A. Reina, Peter J. Savage, Neil Schneiderman, Gregory A. Talavera, Catherine C. Cowie

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To determine the prevalence of Hispanic/Latino adults with diabetes who meet target hemoglobin A1c, blood pressure (BP), and low-density-lipoprotein cholesterol (LDL-C) recommendations, and angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blocker (ARB) and statin medication use by heritage and sociodemographic and diabetes-related characteristics. Methods: Data were cross-sectional, collected between 2008 and 2011, and included adults age 18 to 74 years who reported a physician diagnosis of diabetes in the Hispanic Community Health Study/Study of Latinos (N = 2,148). Chi-square tests compared the prevalence of hemoglobin A1c, BP, and LDL-C targets and ACE/ARB and statin use across participant characteristics. Predictive margins regression was used to determine the prevalence adjusted for sociodemographic characteristics. Results: The overall prevalence of A1c <7.0% (53 mmol/mol), BP <130/80 mm Hg, and LDL-C <100 mg/dL was 43.0, 48.7, and 36.6%, respectively, with 8.4% meeting all three targets. Younger adults aged 18 to 39 years with diabetes were less likely to have A1c <7.0% (53 mmol/mol) or LDL-C <100 mg/dL compared to those aged 65 to 74 years; younger adults were more likely to have BP <130/80 mm Hg (P<.05 for all). Individuals of Mexican heritage were significantly less likely to have A1c <7.0% (53 mmol/mol) compared to those with Cuban heritage, but they were more likely to have BP <130/80 mm Hg compared to those with Dominican, Cuban, or Puerto Rican heritage (P<.05 for all); there was no difference in LDL-C by heritage. Overall, 38.2% of adults with diabetes were taking a statin, and 50.5% were taking ACE/ARB medications. Conclusion: Hemoglobin A1c, BP, and LDL-C control are suboptimal among Hispanic/Latinos with diabetes living in the U.S. With 8.4% meeting all three recommendations, substantial opportunity exists to improve diabetes control in this population. Abbreviations: A1c = hemoglobin A1c; ABC = hemoglobin A1c, blood pressure, low-density-lipoprotein cholesterol; ACE = angiotensin-converting enzyme; ADA = American Diabetes Association; ARB = angiotensin receptor blocker; BMI = body mass index; BP = blood pressure; CHD = coronary heart disease; CVD = cardiovascular disease; HCHS/SOL = Hispanic Community Health Study/Study of Latinos; LDL-C = low-density-lipoprotein cholesterol; NHANES = National Health and Nutrition Examination Survey; PAD = peripheral artery disease.

Original languageEnglish (US)
Pages (from-to)1232-1253
Number of pages22
JournalEndocrine Practice
Volume23
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Hispanic Americans
LDL Cholesterol
Hemoglobins
Blood Pressure
Angiotensin Receptor Antagonists
Health
Peptidyl-Dipeptidase A
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Nutrition Surveys
Young Adult
oxidized low density lipoprotein
Peripheral Arterial Disease
Chi-Square Distribution
Angiotensin-Converting Enzyme Inhibitors
Coronary Disease
Body Mass Index
Cardiovascular Diseases
Physicians
Population

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

HEMOGLOBIN A1C, BLOOD PRESSURE, and LDL-CHOLESTEROL CONTROL among HISPANIC/LATINO ADULTS with DIABETES : RESULTS from the HISPANIC COMMUNITY HEALTH STUDY/STUDY of LATINOS (HCHS/SOL). / Casagrande, Sarah Stark; Aviles-Santa, Larissa; Corsino, Leonor; Daviglus, Martha L.; Gallo, Linda C.; Espinoza Giacinto, Rebeca A.; Llabre, Maria; Reina, Samantha A.; Savage, Peter J.; Schneiderman, Neil; Talavera, Gregory A.; Cowie, Catherine C.

In: Endocrine Practice, Vol. 23, No. 10, 01.10.2017, p. 1232-1253.

Research output: Contribution to journalArticle

Casagrande, SS, Aviles-Santa, L, Corsino, L, Daviglus, ML, Gallo, LC, Espinoza Giacinto, RA, Llabre, M, Reina, SA, Savage, PJ, Schneiderman, N, Talavera, GA & Cowie, CC 2017, 'HEMOGLOBIN A1C, BLOOD PRESSURE, and LDL-CHOLESTEROL CONTROL among HISPANIC/LATINO ADULTS with DIABETES: RESULTS from the HISPANIC COMMUNITY HEALTH STUDY/STUDY of LATINOS (HCHS/SOL)', Endocrine Practice, vol. 23, no. 10, pp. 1232-1253. https://doi.org/10.4158/EP171765.OR
Casagrande, Sarah Stark ; Aviles-Santa, Larissa ; Corsino, Leonor ; Daviglus, Martha L. ; Gallo, Linda C. ; Espinoza Giacinto, Rebeca A. ; Llabre, Maria ; Reina, Samantha A. ; Savage, Peter J. ; Schneiderman, Neil ; Talavera, Gregory A. ; Cowie, Catherine C. / HEMOGLOBIN A1C, BLOOD PRESSURE, and LDL-CHOLESTEROL CONTROL among HISPANIC/LATINO ADULTS with DIABETES : RESULTS from the HISPANIC COMMUNITY HEALTH STUDY/STUDY of LATINOS (HCHS/SOL). In: Endocrine Practice. 2017 ; Vol. 23, No. 10. pp. 1232-1253.
@article{1b9b6c4c80c5408fb9f227100b8af687,
title = "HEMOGLOBIN A1C, BLOOD PRESSURE, and LDL-CHOLESTEROL CONTROL among HISPANIC/LATINO ADULTS with DIABETES: RESULTS from the HISPANIC COMMUNITY HEALTH STUDY/STUDY of LATINOS (HCHS/SOL)",
abstract = "Objective: To determine the prevalence of Hispanic/Latino adults with diabetes who meet target hemoglobin A1c, blood pressure (BP), and low-density-lipoprotein cholesterol (LDL-C) recommendations, and angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blocker (ARB) and statin medication use by heritage and sociodemographic and diabetes-related characteristics. Methods: Data were cross-sectional, collected between 2008 and 2011, and included adults age 18 to 74 years who reported a physician diagnosis of diabetes in the Hispanic Community Health Study/Study of Latinos (N = 2,148). Chi-square tests compared the prevalence of hemoglobin A1c, BP, and LDL-C targets and ACE/ARB and statin use across participant characteristics. Predictive margins regression was used to determine the prevalence adjusted for sociodemographic characteristics. Results: The overall prevalence of A1c <7.0{\%} (53 mmol/mol), BP <130/80 mm Hg, and LDL-C <100 mg/dL was 43.0, 48.7, and 36.6{\%}, respectively, with 8.4{\%} meeting all three targets. Younger adults aged 18 to 39 years with diabetes were less likely to have A1c <7.0{\%} (53 mmol/mol) or LDL-C <100 mg/dL compared to those aged 65 to 74 years; younger adults were more likely to have BP <130/80 mm Hg (P<.05 for all). Individuals of Mexican heritage were significantly less likely to have A1c <7.0{\%} (53 mmol/mol) compared to those with Cuban heritage, but they were more likely to have BP <130/80 mm Hg compared to those with Dominican, Cuban, or Puerto Rican heritage (P<.05 for all); there was no difference in LDL-C by heritage. Overall, 38.2{\%} of adults with diabetes were taking a statin, and 50.5{\%} were taking ACE/ARB medications. Conclusion: Hemoglobin A1c, BP, and LDL-C control are suboptimal among Hispanic/Latinos with diabetes living in the U.S. With 8.4{\%} meeting all three recommendations, substantial opportunity exists to improve diabetes control in this population. Abbreviations: A1c = hemoglobin A1c; ABC = hemoglobin A1c, blood pressure, low-density-lipoprotein cholesterol; ACE = angiotensin-converting enzyme; ADA = American Diabetes Association; ARB = angiotensin receptor blocker; BMI = body mass index; BP = blood pressure; CHD = coronary heart disease; CVD = cardiovascular disease; HCHS/SOL = Hispanic Community Health Study/Study of Latinos; LDL-C = low-density-lipoprotein cholesterol; NHANES = National Health and Nutrition Examination Survey; PAD = peripheral artery disease.",
author = "Casagrande, {Sarah Stark} and Larissa Aviles-Santa and Leonor Corsino and Daviglus, {Martha L.} and Gallo, {Linda C.} and {Espinoza Giacinto}, {Rebeca A.} and Maria Llabre and Reina, {Samantha A.} and Savage, {Peter J.} and Neil Schneiderman and Talavera, {Gregory A.} and Cowie, {Catherine C.}",
year = "2017",
month = "10",
day = "1",
doi = "10.4158/EP171765.OR",
language = "English (US)",
volume = "23",
pages = "1232--1253",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "10",

}

TY - JOUR

T1 - HEMOGLOBIN A1C, BLOOD PRESSURE, and LDL-CHOLESTEROL CONTROL among HISPANIC/LATINO ADULTS with DIABETES

T2 - RESULTS from the HISPANIC COMMUNITY HEALTH STUDY/STUDY of LATINOS (HCHS/SOL)

AU - Casagrande, Sarah Stark

AU - Aviles-Santa, Larissa

AU - Corsino, Leonor

AU - Daviglus, Martha L.

AU - Gallo, Linda C.

AU - Espinoza Giacinto, Rebeca A.

AU - Llabre, Maria

AU - Reina, Samantha A.

AU - Savage, Peter J.

AU - Schneiderman, Neil

AU - Talavera, Gregory A.

AU - Cowie, Catherine C.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Objective: To determine the prevalence of Hispanic/Latino adults with diabetes who meet target hemoglobin A1c, blood pressure (BP), and low-density-lipoprotein cholesterol (LDL-C) recommendations, and angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blocker (ARB) and statin medication use by heritage and sociodemographic and diabetes-related characteristics. Methods: Data were cross-sectional, collected between 2008 and 2011, and included adults age 18 to 74 years who reported a physician diagnosis of diabetes in the Hispanic Community Health Study/Study of Latinos (N = 2,148). Chi-square tests compared the prevalence of hemoglobin A1c, BP, and LDL-C targets and ACE/ARB and statin use across participant characteristics. Predictive margins regression was used to determine the prevalence adjusted for sociodemographic characteristics. Results: The overall prevalence of A1c <7.0% (53 mmol/mol), BP <130/80 mm Hg, and LDL-C <100 mg/dL was 43.0, 48.7, and 36.6%, respectively, with 8.4% meeting all three targets. Younger adults aged 18 to 39 years with diabetes were less likely to have A1c <7.0% (53 mmol/mol) or LDL-C <100 mg/dL compared to those aged 65 to 74 years; younger adults were more likely to have BP <130/80 mm Hg (P<.05 for all). Individuals of Mexican heritage were significantly less likely to have A1c <7.0% (53 mmol/mol) compared to those with Cuban heritage, but they were more likely to have BP <130/80 mm Hg compared to those with Dominican, Cuban, or Puerto Rican heritage (P<.05 for all); there was no difference in LDL-C by heritage. Overall, 38.2% of adults with diabetes were taking a statin, and 50.5% were taking ACE/ARB medications. Conclusion: Hemoglobin A1c, BP, and LDL-C control are suboptimal among Hispanic/Latinos with diabetes living in the U.S. With 8.4% meeting all three recommendations, substantial opportunity exists to improve diabetes control in this population. Abbreviations: A1c = hemoglobin A1c; ABC = hemoglobin A1c, blood pressure, low-density-lipoprotein cholesterol; ACE = angiotensin-converting enzyme; ADA = American Diabetes Association; ARB = angiotensin receptor blocker; BMI = body mass index; BP = blood pressure; CHD = coronary heart disease; CVD = cardiovascular disease; HCHS/SOL = Hispanic Community Health Study/Study of Latinos; LDL-C = low-density-lipoprotein cholesterol; NHANES = National Health and Nutrition Examination Survey; PAD = peripheral artery disease.

AB - Objective: To determine the prevalence of Hispanic/Latino adults with diabetes who meet target hemoglobin A1c, blood pressure (BP), and low-density-lipoprotein cholesterol (LDL-C) recommendations, and angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blocker (ARB) and statin medication use by heritage and sociodemographic and diabetes-related characteristics. Methods: Data were cross-sectional, collected between 2008 and 2011, and included adults age 18 to 74 years who reported a physician diagnosis of diabetes in the Hispanic Community Health Study/Study of Latinos (N = 2,148). Chi-square tests compared the prevalence of hemoglobin A1c, BP, and LDL-C targets and ACE/ARB and statin use across participant characteristics. Predictive margins regression was used to determine the prevalence adjusted for sociodemographic characteristics. Results: The overall prevalence of A1c <7.0% (53 mmol/mol), BP <130/80 mm Hg, and LDL-C <100 mg/dL was 43.0, 48.7, and 36.6%, respectively, with 8.4% meeting all three targets. Younger adults aged 18 to 39 years with diabetes were less likely to have A1c <7.0% (53 mmol/mol) or LDL-C <100 mg/dL compared to those aged 65 to 74 years; younger adults were more likely to have BP <130/80 mm Hg (P<.05 for all). Individuals of Mexican heritage were significantly less likely to have A1c <7.0% (53 mmol/mol) compared to those with Cuban heritage, but they were more likely to have BP <130/80 mm Hg compared to those with Dominican, Cuban, or Puerto Rican heritage (P<.05 for all); there was no difference in LDL-C by heritage. Overall, 38.2% of adults with diabetes were taking a statin, and 50.5% were taking ACE/ARB medications. Conclusion: Hemoglobin A1c, BP, and LDL-C control are suboptimal among Hispanic/Latinos with diabetes living in the U.S. With 8.4% meeting all three recommendations, substantial opportunity exists to improve diabetes control in this population. Abbreviations: A1c = hemoglobin A1c; ABC = hemoglobin A1c, blood pressure, low-density-lipoprotein cholesterol; ACE = angiotensin-converting enzyme; ADA = American Diabetes Association; ARB = angiotensin receptor blocker; BMI = body mass index; BP = blood pressure; CHD = coronary heart disease; CVD = cardiovascular disease; HCHS/SOL = Hispanic Community Health Study/Study of Latinos; LDL-C = low-density-lipoprotein cholesterol; NHANES = National Health and Nutrition Examination Survey; PAD = peripheral artery disease.

UR - http://www.scopus.com/inward/record.url?scp=85032865601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032865601&partnerID=8YFLogxK

U2 - 10.4158/EP171765.OR

DO - 10.4158/EP171765.OR

M3 - Article

VL - 23

SP - 1232

EP - 1253

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 10

ER -